Q2 Healthtech Market Watch

The latest M&A valuation multiples in the health tech sector indicate a slightly optimistic outlook…

From Incubation to Exit in Biotech

BIO2024 – Two sessions related to M&A in biotech, each offering unique perspectives while sharing…

The looming specter of the 2024 U.S. elections casts a long shadow over its tech…

Serge JonnaertCEO & M&A Advisor – Software & Technology Europe is once again well represented…

Delivering better quality results, faster, more efficiently, and at a lower cost by Serge Jonnaert…

Sharing a presentation I recently did on Artificial Intelligence and Robotic Process Automation in investment…

This is a call-out to all #techCEOs! Prepare yourself for a fun, rich, healthy, and…

Landing ‘a big one’ is still the aspiration of most software CEOs, and rightfully so.…